Remicade is given by a healthcare professional as an intravenous (IV) infusion (an injection into your vein given over a period of time). An interaction can occur because one substance causes ...

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

The co-developer of Remicade, one of the three top-selling drugs in the world, has donated more than $500,000 to fund what will be known as the Iris and Junming Le Foundation Super-Resolution ...

There, Hairston receives an IV infusion with REMICADE, a drug that treats her rare autoimmune disease – non-radiological ...

ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar ... vedolizumab than infliximab (12.1% vs 3.8%) but less infusion reactions (none vs 5.1%) More serious AEs ...